STSA Crosses Above Average Analyst Target
December 22, 2020 at 08:35 AM EST
In recent trading, shares of Satsuma Pharmaceuticals Inc (STSA) have crossed above the average analyst 12-month target price of $5.00, changing hands for $5.04/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..